Hichens, Harisson & Co
Hichens, Harisson & Co
  • About Us
  • Clients
  • B2C B2B SALES
  • Services
  • Events
  • Hichen's Holdings
  • News Archive
  • Contact Us
    • About Us
    • Clients
    • B2C B2B SALES
    • Services
    • Events
    • Hichen's Holdings
    • News Archive
    • Contact Us
  • About Us
  • Clients
  • B2C B2B SALES
  • Services
  • Events
  • Hichen's Holdings
  • News Archive
  • Contact Us

4/29/2020 Hichens Closes $100 Million Dollar Ventilator Deal With Brazil

Find out more
image1055

11/18/2019 - Cognizance Biomarkers featured in Philadelphia Magazine.

Find out more

  


Press Releases

image1056

12/4/2019 - Cognizance Biomarkers Initiates Clinical Trial

Find out more
image1057

9/18/2019 - Cognizance Biomarkers receives $562,000 grant from NIH.

  

Cognizance Biomarkers was awarded, on September 18, 2019, a $562,000 grant from the US National Institute of Health (NIH) for initiation of a clinical trial with the world renowned Mayo Clinic to confirm it's blood based protein biomarker test and algorithm accurately distinguishes epileptic seizures (ES) from psychogenic nonepileptic seizures (PNES).  Dr. Greg Cascino, well known in the Epilepsy physician community is the Enterprise Director of Epilepsy at Mayo Clinic, has published over 200 peer-reviewed articles, presented approximately 400 invited lectures, and will serve as the Principal investigator of the trial.  The clinical trial protocol received full approval from the Mayo Clinic Investigational Review Board (IRB), and trial initiated on November 8, 2019.

image1058

Brazil’s ‘Tropical Trump’ Needs to Build the Wall — Around the Country’s Finances

HH CEO makes comments at the Atlanta Fed, 1/24/2019.

Find out more

Copyright © 2012 - 2021 Hichens, Harisson Capital Partners LLC USA

Development by Hichens, Harrison & Co.

  • Clients
  • B2C B2B SALES
  • Services
  • Events
  • Hichen's Holdings
  • News Archive
  • Contact Us
image1059

SALE of COMEN Machine

 Price on request! 

more information